Triprolidine And Pseudoephedrine

   
Google
 
Web NewDrugInformation.com

Triprolidine And Pseudoephedrine


Drug - Triprolidine And Pseudoephedrine
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Pseudoephedrine Hydrochloride; Triprolidine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 60MG;2.5MG
The potency of the active ingredient(s), Pseudoephedrine Hydrochloride; Triprolidine Hydrochloride. May repeat for multiple part products.

Applicant - WATSON LABS
The firm name holding legal responsibility for Triprolidine And Pseudoephedrine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088318
The FDA assigned number to Triprolidine And Pseudoephedrine. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Triprolidine And Pseudoephedrine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 13, 1984
The date Triprolidine And Pseudoephedrine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Triprolidine And Pseudoephedrine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Triprolidine And Pseudoephedrine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Watson Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Triprolidine And Pseudoephedrine.

Triprolidine And Pseudoephedrine